ANALOG DEVICES INC SEC Filings

Analog Devices Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $108.08 per share, receiving the same number of common shares, then sold 10,000 common shares at $363.00 on August 3, 2026 pursuant to a Rule 10b5-1 plan adopted on December 3, 2025. After the option exercise, he directly holds 70,803 stock options and indirectly holds 23,515 and 50,000 common shares through the Vincent Roche 2024 and 2026 Grantor Retained Annuity Trusts.

ADI filed a Form 144 indicating that Vincent Roche plans to sell 10,000 shares of common stock on 08/03/2026 on NASDAQ, following a stock option exercise for cash. The planned sale is listed through Fidelity Brokerage Services LLC with an aggregate market value of $3,630,000.00.

Over the prior three months, Vincent Roche reported sales of ADI common stock: 30,000 shares for $11,904,549.00 on 05/22/2026, 30,000 shares for $12,453,855.00 on 05/26/2026, 10,000 shares for $4,042,500.00 on 06/01/2026, and 10,000 shares for $3,897,500.00 on 07/01/2026.

Analog Devices, Inc. reported that on June 23, 2026 it identified unauthorized access to certain company systems. It activated incident-response protocols, engaged external cybersecurity experts, notified law enforcement, and states that operations were not interrupted during the incident. The investigation has found that certain files were exfiltrated, and the company is analyzing the nature and scope of the affected information.

Analog Devices says that, to its knowledge, the data has not been publicly released or used for fraudulent purposes. It plans to notify affected parties and regulators as required and will continue monitoring for misuse. Based on information currently known and mitigation steps taken, the company does not believe the incident is reasonably likely to materially impact its business, operations, or financial condition. Separately, the company is assessing public reports about a disparate cybersecurity matter made known on July 26, 2026.

Analog Devices Inc director Karen Golz sold 1,000 shares of common stock in an open-market transaction on July 13, 2026 at $389.83 per share. After this sale, she directly holds 11,019 shares. The trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026.

Analog Devices Inc. insider Karen M. Golz filed a Form 144 indicating an intention to sell 1,000 shares of common stock through Fidelity Brokerage Services LLC on or after July 13, 2026 on the NASDAQ market. The planned sale is shown with an aggregate market value of $389,830.00.

The 1,000 shares proposed for sale were originally acquired from the issuer via restricted stock vesting as compensation on March 11, 2020. The filing also lists a prior sale in the last three months of 1,000 common shares on June 12, 2026 for an aggregate value of $411,950.00.

Analog Devices Inc. director Ray Stata reported open-market sales of 2,832 shares of common stock in early July 2026. The trades, executed over July 7–8, 2026 at prices between about $371 and $389 per share, were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.

Following these transactions, Stata directly holds 115,927 Analog Devices shares. He also reports indirect ownership of 652,221 shares held by his spouse. The filing shows multiple small sale lots, reflecting a structured disposition rather than a single large block trade.

Analog Devices Chair and CEO Vincent Roche reported an option exercise and share sale. On July 1, 2026, he exercised 10,000 Non-Qualified Stock Options at $108.08 per share, acquiring the same number of common shares.

On the same date, he completed an open-market sale of 10,000 common shares at an average price of $389.75 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. Following these transactions, Roche directly holds 137,537.875 common shares, with additional indirect holdings of 50,000 and 23,515 shares in separate Grantor Retained Annuity Trusts.

Analog Devices, Inc. entered into a new Revolving Credit Agreement providing a 364-day revolving credit facility with aggregate commitments of up to $3.0 billion. The facility initially expires on July 1, 2027, with potential one-year extensions on each annual anniversary, subject to lender consent.

The company may borrow, repay and reborrow amounts in multiple currencies, including U.S. dollars, euros and pounds sterling, and may designate certain foreign subsidiaries as additional borrowers, whose obligations it will guarantee. Interest may be based on Term SOFR plus a margin of 0.48%–0.925% or on a Base Rate, and a facility fee of 0.020%–0.075% applies on committed amounts.

The agreement includes customary covenants, events of default and limitations on liens and mergers. It also requires the company to maintain a consolidated EBITDA to consolidated interest coverage ratio of at least 3.00 to 1.00 starting with the first fiscal quarter ending after the closing date.

Vincent T. Roche submitted a Form 144 to sell 10,000 shares of Common Stock via a stock option exercise dated 07/01/2026, to be settled for cash.

The filing also lists multiple sales by Roche during the prior three months, including 30,000 shares on 05/22/2026 for $11,904,549 and 30,000 shares on 05/26/2026 for $12,453,855. The notice identifies the purchaser agent as Fidelity Brokerage Services LLC and the listing exchange as NASDAQ.